Pain News and Research

Latest Pain News and Research

Increase in patient safety results in fewer negative medical outcomes: RAND study

Lisa Maas, executive director of Californians Allied for Patient Protection, issued the following statement in response to a recent study by the RAND Corporation which found that a reduction in the number of preventable patient injuries in California from 2001 to 2005 also corresponded to a drop in malpractice claims.

6 May 2010

Study on risk factors, potential harm associated with medication errors at hospital admission

A recent study conducted at Northwestern Memorial Hospital found that almost 50 percent of medication discrepancies were related to a failure to understand all of the prescription medications patients were taking at the time of hospital admission. While it's common for patients not to recall all of their medications, especially when they are not feeling well or being unexpectedly admitted to the hospital, the results can be serious.

6 May 2010

Colonoscopy preparation drugs administered same day as procedure equally effective: Researchers

Researchers at Thomas Jefferson University have found that colonoscopy preparation drugs administered the same day as the procedure are equally effective to those given the night before and the morning of the procedure, but result in less complaints of side effects such as abdominal pain, sleep loss and workday interference.

6 May 2010

Southeast Pain Care offers non-addictive alternatives to pain relief

The untimely death of Michael Jackson has brought the issue of pain medication addiction to the forefront of American media recently. The good news for people suffering with pain is that there are several non-addictive alternatives to pain relief.

6 May 2010

EpiCept provides update on corporate strategy, reports net loss of $4.5M for first-quarter 2010

EpiCept Corporation today announced operating and financial results for the three months ended March 31, 2010, and provided an update with respect to the Company's key business initiatives.

6 May 2010

Positive results from Phase 2 clinical study of LX1031 in IBS patients presented at DDW 2010

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, presented results from its positive Phase 2 clinical study with LX1031 in patients with non-constipating irritable bowel syndrome at Digestive Disease Week 2010 in New Orleans, Louisiana.

6 May 2010

Jazz Pharmaceuticals reports 59% increase in first-quarter 2010 revenue

Jazz Pharmaceuticals, Inc. announced financial results for the first quarter ended March 31, 2010 and updated guidance for sales and expenses for 2010.

6 May 2010

Endo Pharmaceuticals to acquire all outstanding shares of HealthTronics common stock

HealthTronics, Inc., a leading provider of urological products and services, today announced that it has signed a definitive merger agreement with Endo Pharmaceuticals pursuant to which Endo will acquire HealthTronics.

6 May 2010

Endo Pharmaceuticals signs agreement to acquire HealthTronics

Continuing to diversify, move into new growth areas beyond pharmaceuticals, and strengthen its commitment to improved patient outcomes in urology, Endo Pharmaceuticals today announced that it has signed an agreement to acquire HealthTronics, Inc., a leading U.S. provider of urological products and services.

6 May 2010

FDA approves Provenge for treating men with advanced prostate cancer

The US Food and Drug Administration has approved a new 'cancer vaccine' for treating men with advanced prostate cancer.

6 May 2010

Cadence Pharmaceuticals resubmits OFIRMEV NDA

Cadence Pharmaceuticals, Inc. announced today that it has resubmitted its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its investigational product candidate, OFIRMEV™ (acetaminophen) injection, for the treatment of pain and fever in adults and children.

5 May 2010

Study reveals changes in brain activity in response to withdrawal of life support

At a time when "donation after cardiac death" (DCD) has become an important approach to increasing the number of transplant organ donors, a provocative new study shows changes in brain activity occurring in response to withdrawal of life support, reports the May issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

5 May 2010

Researchers analyze spine surgery patients' existing comorbdities in relationship to hospital stay, costs

It is estimated that between 75 and 85 percent of all Americans will suffer from low back pain and/or neck pain at some point in their lives. An estimated 12 million Americans suffer from degenerative disc disease, with over one million patients undergoing surgery each year. The cost of treating back pain is currently estimated at more than $100 billion annually in the U.S. Many patients with back pain have comorbidities that impact spine surgery.

5 May 2010

MicroStockProfit.com: CRXX's total revenues reach $8.6M in fourth-quarter 2009

MicroStockProfit.com announces an investment report featuring CombinatoRx Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

5 May 2010

Pre-treatment quality-of-life scores predict malignancy in patients with pancreatic disease

Quality-of-life measures used routinely to assess treatment outcomes for patients with pancreatic disease may be used to predict both malignancy and survival for those patients, according to a study by Henry Ford Hospital.

5 May 2010

The practice of medicine: Changes are evident -- From med school training and technology to concierge medicine

Kaiser Health News, in partnership with The New York Times, explores what medical students are taught about health care costs: "Doctors in training have traditionally been insulated from information about the cost of the tests and treatments they order for patients — in fact, for decades, the subject was virtually taboo when professors and trainees discussed treatment decisions during hospital rounds.

5 May 2010

Meda AB's net sales for first-quarter 2010 decrease 14% to SEK 2,943M

After a strong Q4 in 2009, net sales decreased 14% in Q1 to SEK 2,943 million (3,437). Mainly currency effects but also increased competition for Astelin and Optivar reduced sales by more than SEK 400 million, compared with the same period last year.

5 May 2010

Americans and their babies are gaining more body fat: Study

A new study has found for the first time that as Americans are gaining more body fat, so are their babies. The research, which reviewed data from more than 74,000 births, found that a key measure of body fat composition in newborns increased significantly over a 15-year period, mirroring similar increases among pregnant mothers. The findings were presented Sunday by researchers from Children's Mercy Hospitals and Clinics at the Pediatric Academic Societies annual meeting.

5 May 2010

New pathology test may help doctors distinguish between two overlapping esophageal disorders: Study

A pathology test may help doctors distinguish between two separate but overlapping esophageal disorders that require different courses of treatment, according to a study by researchers at the University of North Carolina at Chapel Hill.

5 May 2010

Orexo AB reports net revenues of MSEK 36.4 for January-March 2010

During the first quarter of the year, we experienced strong growth in sales of Abstral to end customers in Europe. Abstral continued to grow sales in all markets and is now the market leader in cancer pain drugs in the UK.

5 May 2010

Pain News and Research

Latest Pain News and Research

Increase in patient safety results in fewer negative medical outcomes: RAND study

Study on risk factors, potential harm associated with medication errors at hospital admission

Colonoscopy preparation drugs administered same day as procedure equally effective: Researchers

Southeast Pain Care offers non-addictive alternatives to pain relief

EpiCept provides update on corporate strategy, reports net loss of $4.5M for first-quarter 2010

Positive results from Phase 2 clinical study of LX1031 in IBS patients presented at DDW 2010

Jazz Pharmaceuticals reports 59% increase in first-quarter 2010 revenue

Endo Pharmaceuticals to acquire all outstanding shares of HealthTronics common stock

Endo Pharmaceuticals signs agreement to acquire HealthTronics

FDA approves Provenge for treating men with advanced prostate cancer

Cadence Pharmaceuticals resubmits OFIRMEV NDA

Study reveals changes in brain activity in response to withdrawal of life support

Researchers analyze spine surgery patients' existing comorbdities in relationship to hospital stay, costs

MicroStockProfit.com: CRXX's total revenues reach $8.6M in fourth-quarter 2009

Pre-treatment quality-of-life scores predict malignancy in patients with pancreatic disease

The practice of medicine: Changes are evident -- From med school training and technology to concierge medicine

Meda AB's net sales for first-quarter 2010 decrease 14% to SEK 2,943M

Americans and their babies are gaining more body fat: Study

New pathology test may help doctors distinguish between two overlapping esophageal disorders: Study

Orexo AB reports net revenues of MSEK 36.4 for January-March 2010

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Pain News and Research

Latest Pain News and Research

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in